Birdwatch Note
2024-04-25 00:54:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
O uso da doxiciclina como profilaxia de pós-exposição (quando há o contato de risco) para as IST's citadas ainda está em fase experimental. Além disso, o uso incorreto de antibióticos contribui para o desenvolvimento de bactérias resistentes. https://agenciaaids.com.br/noticia/eua-divulgam-primeiras-diretrizes-para-o-uso-da-doxiciclina-antibiotico-usado-pos-sexo-para-prevenir-ists/
Written by CD2E8F070D441E5E65C7432FC5C8AA44B045778E4715FB44271157CDD7B27736
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1783264863734600076
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1783298395324444711
- noteId - 1783298395324444711
- participantId -
- noteAuthorParticipantId - CD2E8F070D441E5E65C7432FC5C8AA44B045778E4715FB44271157CDD7B27736 Participant Details
- createdAtMillis - 1714006444184
- tweetId - 1783264863734600076
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- O uso da doxiciclina como profilaxia de pós-exposição (quando há o contato de risco) para as IST's citadas ainda está em fase experimental. Além disso, o uso incorreto de antibióticos contribui para o desenvolvimento de bactérias resistentes. https://agenciaaids.com.br/noticia/eua-divulgam-primeiras-diretrizes-para-o-uso-da-doxiciclina-antibiotico-usado-pos-sexo-para-prevenir-ists/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-25 00:54:04 UTC (1714006444184) |
2024-04-25 03:32:32 UTC (1714015952773) |
CURRENTLY_RATED_HELPFUL | 2024-04-26 05:28:59 UTC (1714109339772) |
CURRENTLY_RATED_HELPFUL | 2024-04-25 03:32:32 UTC (1714015952773) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-25 18:04:26 -0500 | Rating Details | |
| 2024-04-25 15:55:47 -0500 | Rating Details | |
| 2024-04-25 13:27:30 -0500 | Rating Details | |
| 2024-04-25 09:55:44 -0500 | Rating Details | |
| 2024-04-25 07:41:04 -0500 | Rating Details | |
| 2024-04-25 07:39:56 -0500 | Rating Details | |
| 2024-04-25 06:39:11 -0500 | Rating Details | |
| 2024-04-25 04:47:45 -0500 | Rating Details | |
| 2024-04-25 04:34:39 -0500 | Rating Details | |
| 2024-04-25 04:06:49 -0500 | Rating Details | |
| 2024-04-25 01:47:37 -0500 | Rating Details | |
| 2024-04-24 22:31:11 -0500 | Rating Details | |
| 2024-04-24 22:25:06 -0500 | Rating Details | |
| 2024-04-24 22:11:42 -0500 | Rating Details | |
| 2024-04-24 21:59:05 -0500 | Rating Details | |
| 2024-04-24 21:52:12 -0500 | Rating Details | |
| 2024-04-24 21:49:19 -0500 | Rating Details | |
| 2024-04-24 21:40:31 -0500 | Rating Details | |
| 2024-04-24 21:40:17 -0500 | Rating Details | |
| 2024-04-24 21:27:09 -0500 | Rating Details | |
| 2024-04-24 21:25:56 -0500 | Rating Details | |
| 2024-04-24 21:12:50 -0500 | Rating Details | |
| 2024-04-24 21:07:35 -0500 | Rating Details | |
| 2024-04-24 21:02:00 -0500 | Rating Details | |
| 2024-04-24 20:45:11 -0500 | Rating Details | |
| 2024-04-24 20:34:12 -0500 | Rating Details | |
| 2024-04-24 20:33:19 -0500 | Rating Details | |
| 2024-04-24 20:32:45 -0500 | Rating Details | |
| 2024-04-24 20:26:41 -0500 | Rating Details | |
| 2024-04-24 20:21:36 -0500 | Rating Details | |
| 2024-04-24 20:05:30 -0500 | Rating Details | |
| 2024-04-24 19:56:33 -0500 | Rating Details | |
| 2024-04-24 19:55:28 -0500 | Rating Details | |
| 2024-04-25 20:27:32 -0500 | Rating Details | |
| 2024-04-25 15:03:16 -0500 | Rating Details | |
| 2024-04-25 12:43:56 -0500 | Rating Details | |
| 2024-04-25 09:45:21 -0500 | Rating Details | |
| 2024-04-25 09:11:40 -0500 | Rating Details | |
| 2024-04-25 08:24:42 -0500 | Rating Details | |
| 2024-04-25 08:03:56 -0500 | Rating Details | |
| 2024-04-25 07:32:30 -0500 | Rating Details | |
| 2024-04-25 04:45:14 -0500 | Rating Details | |
| 2024-04-25 04:03:01 -0500 | Rating Details | |
| 2024-04-25 01:48:32 -0500 | Rating Details | |
| 2024-04-24 23:27:26 -0500 | Rating Details | |
| 2024-04-24 22:23:21 -0500 | Rating Details | |
| 2024-04-24 22:21:25 -0500 | Rating Details | |
| 2024-04-24 22:16:45 -0500 | Rating Details | |
| 2024-04-24 22:10:29 -0500 | Rating Details | |
| 2024-04-24 22:03:23 -0500 | Rating Details | |
| 2024-04-24 21:45:27 -0500 | Rating Details | |
| 2024-04-24 21:34:04 -0500 | Rating Details | |
| 2024-04-24 21:32:05 -0500 | Rating Details | |
| 2024-04-24 21:20:48 -0500 | Rating Details | |
| 2024-04-24 21:18:09 -0500 | Rating Details | |
| 2024-04-24 21:13:05 -0500 | Rating Details | |
| 2024-04-24 21:08:45 -0500 | Rating Details | |
| 2024-04-24 20:50:37 -0500 | Rating Details | |
| 2024-04-24 20:47:05 -0500 | Rating Details | |
| 2024-04-24 20:37:18 -0500 | Rating Details | |
| 2024-04-24 20:30:40 -0500 | Rating Details | |
| 2024-04-24 20:25:28 -0500 | Rating Details | |
| 2024-04-24 20:19:53 -0500 | Rating Details | |
| 2024-04-24 20:16:19 -0500 | Rating Details | |
| 2024-04-29 20:11:27 -0500 | Rating Details | |
| 2024-04-27 09:46:51 -0500 | Rating Details | |
| 2024-04-27 12:43:02 -0500 | Rating Details | |
| 2024-04-27 09:05:06 -0500 | Rating Details | |
| 2024-04-25 10:21:09 -0500 | Rating Details | |
| 2024-04-25 08:23:14 -0500 | Rating Details | |
| 2024-04-25 08:06:40 -0500 | Rating Details | |
| 2024-04-25 07:59:00 -0500 | Rating Details | |
| 2024-04-25 07:37:50 -0500 | Rating Details | |
| 2024-04-25 07:12:24 -0500 | Rating Details | |
| 2024-04-25 04:09:36 -0500 | Rating Details | |
| 2024-04-24 23:54:39 -0500 | Rating Details | |
| 2024-04-24 22:25:53 -0500 | Rating Details | |
| 2024-04-24 22:00:14 -0500 | Rating Details | |
| 2024-04-24 21:53:14 -0500 | Rating Details | |
| 2024-04-24 21:31:03 -0500 | Rating Details | |
| 2024-04-24 21:09:35 -0500 | Rating Details | |
| 2024-04-24 21:09:23 -0500 | Rating Details | |
| 2024-04-24 21:01:55 -0500 | Rating Details | |
| 2024-04-24 20:58:04 -0500 | Rating Details | |
| 2024-04-24 20:53:06 -0500 | Rating Details | |
| 2024-04-24 20:49:54 -0500 | Rating Details | |
| 2024-04-24 20:46:49 -0500 | Rating Details | |
| 2024-04-24 20:43:18 -0500 | Rating Details | |
| 2024-04-24 20:38:12 -0500 | Rating Details | |
| 2024-04-24 20:35:28 -0500 | Rating Details | |
| 2024-04-24 20:32:35 -0500 | Rating Details | |
| 2024-04-24 20:30:58 -0500 | Rating Details | |
| 2024-04-24 20:25:29 -0500 | Rating Details | |
| 2024-04-24 20:22:23 -0500 | Rating Details | |
| 2024-04-24 20:10:06 -0500 | Rating Details | |
| 2024-04-24 19:55:10 -0500 | Rating Details | |
| 2024-04-29 11:13:46 -0500 | Rating Details | |
| 2024-04-27 09:19:07 -0500 | Rating Details | |
| 2024-04-27 09:02:05 -0500 | Rating Details | |
| 2024-04-27 08:26:58 -0500 | Rating Details | |
| 2024-04-27 06:58:02 -0500 | Rating Details | |
| 2024-04-26 20:28:00 -0500 | Rating Details | |
| 2024-04-26 04:59:05 -0500 | Rating Details | |
| 2024-04-25 16:31:02 -0500 | Rating Details | |
| 2024-04-25 16:28:34 -0500 | Rating Details | |
| 2024-04-25 15:08:41 -0500 | Rating Details | |
| 2024-04-25 10:56:15 -0500 | Rating Details | |
| 2024-04-25 09:17:53 -0500 | Rating Details | |
| 2024-04-25 09:04:47 -0500 | Rating Details | |
| 2024-04-25 08:27:39 -0500 | Rating Details | |
| 2024-04-25 07:28:49 -0500 | Rating Details | |
| 2024-04-25 07:23:25 -0500 | Rating Details | |
| 2024-04-25 06:32:33 -0500 | Rating Details | |
| 2024-04-25 06:27:31 -0500 | Rating Details | |
| 2024-04-25 00:34:39 -0500 | Rating Details | |
| 2024-04-24 22:30:07 -0500 | Rating Details | |
| 2024-04-24 22:24:03 -0500 | Rating Details | |
| 2024-04-24 22:20:09 -0500 | Rating Details | |
| 2024-04-24 22:11:16 -0500 | Rating Details | |
| 2024-04-24 22:04:24 -0500 | Rating Details | |
| 2024-04-24 22:03:57 -0500 | Rating Details | |
| 2024-04-24 21:58:59 -0500 | Rating Details | |
| 2024-04-24 21:44:07 -0500 | Rating Details | |
| 2024-04-24 21:41:58 -0500 | Rating Details | |
| 2024-04-24 21:16:23 -0500 | Rating Details | |
| 2024-04-24 21:13:53 -0500 | Rating Details | |
| 2024-04-24 21:02:09 -0500 | Rating Details | |
| 2024-04-24 20:58:26 -0500 | Rating Details | |
| 2024-04-24 20:55:08 -0500 | Rating Details | |
| 2024-04-24 20:53:01 -0500 | Rating Details | |
| 2024-04-24 20:51:44 -0500 | Rating Details | |
| 2024-04-24 20:45:57 -0500 | Rating Details | |
| 2024-04-24 20:44:35 -0500 | Rating Details | |
| 2024-04-24 20:39:18 -0500 | Rating Details | |
| 2024-04-24 20:37:51 -0500 | Rating Details | |
| 2024-04-24 20:34:56 -0500 | Rating Details | |
| 2024-04-24 20:31:57 -0500 | Rating Details | |
| 2024-04-24 20:30:19 -0500 | Rating Details | |
| 2024-04-24 20:04:02 -0500 | Rating Details | |
| 2024-04-25 07:33:13 -0500 | Rating Details | |
| 2024-04-24 20:18:20 -0500 | Rating Details | |
| 2024-04-24 20:13:12 -0500 | Rating Details | |
| 2024-04-27 12:32:21 -0500 | Rating Details | |
| 2024-04-27 09:02:02 -0500 | Rating Details | |
| 2024-04-26 07:51:36 -0500 | Rating Details |